Global Retirement Partners LLC Raises Holdings in Agilent Technologies, Inc. (NYSE:A)

Global Retirement Partners LLC raised its stake in Agilent Technologies, Inc. (NYSE:AFree Report) by 31.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,905 shares of the medical research company’s stock after purchasing an additional 459 shares during the quarter. Global Retirement Partners LLC’s holdings in Agilent Technologies were worth $249,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Kepos Capital LP boosted its stake in Agilent Technologies by 3.5% in the third quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock valued at $310,000 after acquiring an additional 93 shares during the period. Ancora Advisors LLC boosted its stake in Agilent Technologies by 41.1% in the first quarter. Ancora Advisors LLC now owns 326 shares of the medical research company’s stock valued at $45,000 after acquiring an additional 95 shares during the period. Rosenberg Matthew Hamilton boosted its position in shares of Agilent Technologies by 51.1% during the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after buying an additional 96 shares during the period. Ronald Blue Trust Inc. boosted its position in shares of Agilent Technologies by 8.1% during the third quarter. Ronald Blue Trust Inc. now owns 1,336 shares of the medical research company’s stock worth $161,000 after buying an additional 100 shares during the period. Finally, Invesco LLC boosted its position in shares of Agilent Technologies by 0.7% during the third quarter. Invesco LLC now owns 15,471 shares of the medical research company’s stock worth $1,730,000 after buying an additional 101 shares during the period.

Agilent Technologies Price Performance

NYSE A opened at $143.73 on Thursday. The stock has a market capitalization of $42.12 billion, a P/E ratio of 34.28, a P/E/G ratio of 4.41 and a beta of 1.11. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $151.58. The business’s fifty day moving average is $139.08 and its two-hundred day moving average is $127.25. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.07. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The firm had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the company posted $1.37 EPS. The company’s quarterly revenue was down 5.5% compared to the same quarter last year. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.51 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Monday, April 1st. Agilent Technologies’s payout ratio is 22.38%.

Insiders Place Their Bets

In other Agilent Technologies news, VP Rodney Gonsalves sold 4,828 shares of Agilent Technologies stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now directly owns 21,329 shares in the company, valued at approximately $3,178,021. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CEO Michael R. Mcmullen sold 52,297 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the transaction, the chief executive officer now directly owns 253,909 shares in the company, valued at approximately $38,086,350. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 4,828 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now owns 21,329 shares in the company, valued at $3,178,021. The disclosure for this sale can be found here. In the last three months, insiders have sold 61,610 shares of company stock worth $9,220,333.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on A shares. The Goldman Sachs Group boosted their price objective on Agilent Technologies from $128.00 to $145.00 and gave the stock a “buy” rating in a research report on Thursday, December 7th. UBS Group boosted their price objective on Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 28th. Citigroup boosted their price objective on Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 28th. TheStreet raised Agilent Technologies from a “c+” rating to a “b-” rating in a report on Friday, December 8th. Finally, StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 19th. One analyst has rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $138.29.

Get Our Latest Stock Report on A

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Read More

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.